A CASE OF LUNG ADENOCARCINOMA RESISTANT TO CRIZOTINIB HARBORING KRAS MUTATION AND EML4-ALK FUSION GENE

被引：0
|
作者：
Anai, Satoshi [1 ]
Suzuki, Kunihiro [1 ]
Sueishi, Katsuo [2 ]
Harada, Taishi [1 ]
Toyokawa, Gouji [3 ]
Seto, Takashi [3 ]
Takenoyama, Mitsuhiro [3 ]
Takayama, Koichi [1 ]
Ichinose, Yukito [3 ]
Nakanishi, Yoichi [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan
[2] Kyushu Univ, Dept Pathol, Div Pathophysiol & Expt Pathol, Fukuoka 812, Japan
[3] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu436.33
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-16-5
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB
    Menefee, Michael E.
    D'Amico, Thomas A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1315 - S1316
  • [2] A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
    Tanaka, Hisashi
    Hayashi, Akihito
    Morimoto, Takeshi
    Taima, Kageaki
    Tanaka, Yoshihito
    Shimada, Michiko
    Kurose, Akira
    Takanashi, Shingo
    Okumura, Ken
    [J]. BMC CANCER, 2012, 12
  • [3] A Case of Lung Adenocarcinoma Resistant to Crizotinib Harboring a Novel EML4-ALK Variant, Exon 6 of EML4 Fused to Exon 18 of ALK
    Anai, Satoshi
    Takeshita, Masafumi
    Ando, Nobuhisa
    Ikematsu, Yuuki
    Mishima, Shohei
    Ishida, Koichi
    Inoue, Kouji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : E126 - +
  • [4] A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK fusion gene
    Chen, Xiaoxia
    Zhang, Jie
    Hu, Qiong
    Li, Xuefei
    Zhou, Caicun
    [J]. LUNG CANCER, 2013, 81 (02) : 308 - 310
  • [5] Good Response to Gefitinib in Lung Adenocarcinoma Harboring Coexisting EML4-ALK Fusion Gene and EGFR Mutation
    Kuo, Yao-Wen
    Wu, Shang-Gin
    Ho, Chao-Chi
    Shih, Jin-Yuan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : 2039 - 2040
  • [6] Clinical effect of crizotinib on lung cancer patients with EML4-ALK fusion gene mutation
    Wang, Zhiyong
    Wang, Wei
    Kong, Xiaodong
    Li, Guangxu
    Yang, Weiwei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11632 - 11638
  • [7] A Case of Small Cell Lung Carcinoma Harboring an EML4-ALK Fusion with Partial Response to Crizotinib
    Shen, Qian
    Kalyani, Farhin Shaheed
    Qu, Jingjing
    Chen, Zhen
    Zhang, Jing
    Zhou, Jianying
    [J]. CLINICAL LUNG CANCER, 2021, 22 (06) : E799 - E803
  • [8] A New Human Lung Adenocarcinoma Cell Line Harboring the EML4-ALK Fusion Gene
    Isozaki, Hideko
    Yasugi, Masayuki
    Takigawa, Nagio
    Hotta, Katsuyuki
    Ichihara, Eiki
    Taniguchi, Akihiko
    Toyooka, Shinichi
    Hashida, Shinsuke
    Sendo, Toshiaki
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (10) : 963 - 968
  • [9] EML4-ALK FUSION GENE IN LUNG ADENOCARCINOMA IN THAILAND
    Prempree, Thongbliew
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1023 - S1024
  • [10] Primary lung adenocarcinoma with breast metastasis harboring the EML4-ALK fusion: A case report
    Zhang, Wenwen
    Zhang, Yu
    Zhou, Lei
    Tan, Na
    Bai, Yuju
    Xing, Shiyun
    [J]. ONCOLOGY LETTERS, 2024, 27 (06)
12345